Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides
- PMID: 1370586
- PMCID: PMC48320
- DOI: 10.1073/pnas.89.2.768
Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides
Abstract
We have demonstrated that the synthesis of cDNA by avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptases can be prevented by oligonucleotides bound to the RNA template approximately 100 nucleotides remote from the 3' end of the primer. The RNA was truncated at the level of the antisense oligonucleotide-RNA duplex during the reverse transcription. The key role played by the reverse transcriptase-associated RNase H activity in the inhibition process was shown by the use of (i) inhibitors of RNase H (NaF or dAMP), (ii) Moloney murine leukemia virus reverse transcriptase devoid of RNase H activity, or (iii) alpha-analogues of oligomers that do not elicit RNase H-catalyzed RNA degradation. In all three cases the inhibitory effect was either reduced (NaF, dAMP) or totally abolished. However, an alpha-oligomer bound to the sequence immediately adjacent to the primer-binding site prevented reverse transcription. Therefore, initiation of polymerization can be blocked by means of an RNase H-independent mechanism, whereas arrest of a growing cDNA strand can be achieved only by an oligonucleotide mediating cleavage of the template RNA.
Similar articles
-
Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.Nucleic Acids Symp Ser. 1993;(29):67-8. Nucleic Acids Symp Ser. 1993. PMID: 7504249
-
Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.J Mol Biol. 1999 Dec 17;294(5):1097-113. doi: 10.1006/jmbi.1999.3325. J Mol Biol. 1999. PMID: 10600369
-
Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.FEBS Lett. 1993 Sep 13;330(2):161-4. doi: 10.1016/0014-5793(93)80264-u. FEBS Lett. 1993. PMID: 7689980
-
[Inhibition of gene expression by antisense DNA].Nihon Rinsho. 1995 Mar;53(3):771-8. Nihon Rinsho. 1995. PMID: 7535367 Review. Japanese.
-
Is irrelevant cleavage the price of antisense efficacy?Pharmacol Ther. 2000 Mar;85(3):231-6. doi: 10.1016/s0163-7258(99)00053-4. Pharmacol Ther. 2000. PMID: 10739877 Review.
Cited by
-
Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.J Virol. 2002 Mar;76(6):3015-22. doi: 10.1128/jvi.76.6.3015-3022.2002. J Virol. 2002. PMID: 11861867 Free PMC article.
-
Synthesis and hybridization properties of oligonucleotides containing 2'-O-modified ribonucleotides.Nucleic Acids Res. 1993 Sep 25;21(19):4499-505. doi: 10.1093/nar/21.19.4499. Nucleic Acids Res. 1993. PMID: 8233783 Free PMC article.
-
Antiviral therapy for human immunodeficiency virus infections.Clin Microbiol Rev. 1995 Apr;8(2):200-39. doi: 10.1128/CMR.8.2.200. Clin Microbiol Rev. 1995. PMID: 7542558 Free PMC article. Review.
-
In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.Nucleic Acids Res. 1992 Nov 25;20(22):5999-6006. doi: 10.1093/nar/20.22.5999. Nucleic Acids Res. 1992. PMID: 1281317 Free PMC article.
-
Antisense inhibition of virus infections.Adv Pharmacol. 1997;40:437-83. doi: 10.1016/s1054-3589(08)60147-7. Adv Pharmacol. 1997. PMID: 9217933 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources